Information Circular 5/2010: LARIUM SIDE EFFECTS

By Deputy General Secretary

PDFORRA has been engaged in discussions regarding the appropriate anti-malaria drug that should be issued to members who are serving overseas on missions where a malaria risks exists. The question of side effects from taking Larium has been a constant feature of these discussions.

 PDFORRA wishes to establish to what extent members have developed or believed that they have developed side effects from taking larium – particularly where this has had a lasting effect.

 Members who have experienced or believe they have experienced larium side effects are asked to pass their details, on a confidential basis, to Gerry Rooney, General Secretary. This information will allow PDFORRA to estimate the number of cases that exist.

 PDFORRA is also determining which anti-malaria drug is used by colleagues in other EU armed forces represented by EUROMIL and by other Irish Public Servants who serve overseas as part of their duties.

Comments are closed.